Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,901 | -21,678 | -9,332 | -25,990 | -13,800 |
| Depreciation Amortization | 840 | 1,295 | 139 | 520 | 380 |
| Other Working Capital | -6,654 | 221 | 130 | 2,770 | 640 |
| Other Operating Activity | 1,676 | 25 | 25 | 2,860 | 370 |
| Operating Cash Flow | $-39,039 | $-20,137 | $-9,037 | $-19,840 | $-12,410 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -200 | 25 | -106 | -1,249 | N/A |
| PPE Investments | -561 | -200 | -100 | -430 | -340 |
| Purchase Of Investment | N/A | -27 | -6 | N/A | N/A |
| Other Investing Activity | 68 | 0 | 0 | 9 | -1,110 |
| Investing Cash Flow | $-693 | $-202 | $-211 | $-1,670 | $-1,450 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,467 | 9,417 | N/A | N/A | N/A |
| Debt Repayment | -286 | -121 | -124 | -474 | N/A |
| Common Stock Issued | 28,608 | 16,354 | 9,478 | 24,143 | N/A |
| Dividend Paid | N/A | N/A | N/A | -130 | -110 |
| Other Financing Activity | 4,319 | -65 | 62 | 3,611 | 16,970 |
| Financing Cash Flow | $42,108 | $25,584 | $9,416 | $27,150 | $16,860 |
| Beginning Cash Position | 6,726 | 6,726 | 6,726 | 1,090 | 1,090 |
| End Cash Position | 9,103 | 11,972 | 6,894 | 6,720 | 4,090 |
| Net Cash Flow | $2,377 | $5,246 | $168 | $5,620 | $2,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,039 | -20,137 | -9,037 | -19,840 | -12,410 |
| Capital Expenditure | -561 | -200 | -100 | -430 | N/A |
| Free Cash Flow | -39,600 | -20,336 | -9,137 | -20,270 | -12,410 |